BioMarin

BioMarin
A global biotechnology company focused on developing and commercializing therapies for rare genetic diseases.
About
What does BioMarin do?
BioMarin is a global biotechnology company focused on delivering medicines for people living with rare genetic conditions. They pursue bold science to translate genetic discoveries into new medicines, aiming to unleash the full potential of genetic science by pursuing category-defining therapies that have a profound impact on patients. BioMarin serves patients living with rare conditions, with a particular focus on genetically defined conditions.
What is BioMarin's revenue?
StartupHub estimates BioMarin's annual revenue at $292.0M (range $167.6M to $928.9M, 68% confidence), based on comparable companies in the sector.
What is BioMarin's valuation?
StartupHub estimates BioMarin's effective valuation at $74.3B (range $34.4B to $111.1B, 57% confidence), based on comparable companies in the sector.
Where is BioMarin headquartered?
BioMarin is headquartered in San Rafael, California, United States.
When was BioMarin founded?
BioMarin was founded in 1997.
What industry does BioMarin operate in?
BioMarin operates in Biotechnology, Rare Diseases, Genetic Disorders, Enzyme Replacement Therapies, Drug Discovery, Pharmaceuticals.
How many employees does BioMarin have?
BioMarin has approximately 3163 people on record.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.
A deep-tech company developing nanorobotic solutions for healthcare, initially targeting dental care applications.
MatrixCode is a research focus at the Freiburg Institute for Advanced Studies (FRIAS) investigating matrisome pathology.
A company focused on privacy, Zcash accumulation, and developing cancer therapeutics.
An entrant is a company tagged Biotechnology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.
